Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 124Lymphoma 71Lymphoma, Non-Hodgkin 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 52Myelodysplastic Syndromes 50Neoplasms, Plasma Cell 48Hodgkin Disease 48Leukemia 42Leukemia, Lymphocytic, Chronic, B-Cell 40Lymphoma, Mantle-Cell 35Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 33Burkitt Lymphoma 24Lymphoma, B-Cell, Marginal Zone 22Lymphoma, Large-Cell, Immunoblastic 21Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21Myeloproliferative Disorders 20Recurrence 19Hematologic Neoplasms 19Immunoglobulin Light-chain Amyloidosis 18Leukemia, Myelomonocytic, Chronic 16Neuroblastoma 15Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 15Graft vs Host Disease 15Dendritic Cell Sarcoma, Interdigitating 15Anemia, Refractory, with Excess of Blasts 14Waldenstrom Macroglobulinemia 12Primary Myelofibrosis 12

Interventions

antineoplaston AS 2-1 4antineoplaston A10 4Cyclophosphamide 4Cisplatin 4Temozolomide 3Radiotherapy 3dactolisib 2Vincristine 2Filgrastim 2Everolimus 2Etoposide 2Bevacizumab 2spartalizumab 1sargramostim 1pasireotide 1ganitumab 1gallium Ga 68 dotatate 1fosbretabulin 1cixutumumab 1belzutifan 1aldesleukin 1Topotecan 1Thiotepa 1TH 302 1Sunitinib 1Standard of Care 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroectodermal Tumors, Primitive × Melphalan × Clear all
NCT00180791 2007-09-18

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
71 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡